Litigation Details for VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2018)
✉ Email this page to a colleague
VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-09-06 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Brian R. Martinotti |
| Jury Demand | Defendant | Referred To | Lois H. Goodman |
| Patents | 7,214,506; 8,039,494; 8,486,978; 9,302,009; 9,566,272; 9,662,394; 9,861,698; 9,877,955 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. ZYDUS PHARMACEUTICALS (USA) INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-05-07 | 156 | Opinion | 1 The patents-in-suit are United States Patent Nos. 7,214,506 (“the’506 patent”), 8,039,494 (…include ’978 patent claims 2 and 21, ’494 patent claim 1, ’009 patent claim 1, ’444 patent claim 9, ’698… (“the ’494 patent”), 8,486,978 (“the ’978 patent”), 9,302,009 (“the ’009 patent”), 9,566,272 (“the …the ’272 patent”), 9,662,394 (“the ’394 patent”), 9,861,698 (“the ’698 patent”) and 9,877,955 (“the ’955…’955 patent”) arising under the United States patent laws, Title 35, U.S.C. § 100 et seq., including | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
